Lion TCR Competitors and Similar CompaniesClear all
Lion TCR's competitors and similar companies include MABION, Adagene, UT Health San Antonio MD Anderson Cancer Center and Mirati Therapeutics.
 Lion TCR Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. |  MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Adagene Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy. |  UT Health San Antonio MD Anderson Cancer Center UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care. |  Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. | |
Founding Date | Founding Date N/A | Founding Date 2007 | Founding Date 2012 | Founding Date N/A | Founding Date 2013 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Singapore, SG HQ Guangzhou, CN Singapore, SG Singapore, SG | Locations Konstantynów Łódzki, PL HQ | Locations Suzhou, CN HQ San Diego, US San Francisco, US | Locations San Antonio, US HQ | Locations San Diego, US HQ Zug, CH |
Employees | Employees N/A | Employees 95 | Employees 13821% decrease | Employees N/A | Employees 666% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 21.7 m | Valuation ($) 137.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) zł15.8m (FY, 2025) | Revenue (est.) $7.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $12.4m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods zł24.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $600k (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit (zł7.2m) (FY, 2025) | Gross profit $7.7m (FY, 2025) | Gross profit N/A | Gross profit $11.8m (FY, 2022) |
Net income | Net income N/A | Net income (zł62.6m) (FY, 2025) | Net income ($17.6m) (FY, 2025) | Net income N/A | Net income ($740.9m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 20m | Total funding raised N/A | Total funding raised $ 155m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
MABION
HQ
Konstantynów Łódzki, PL
Employees
95
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View companyAdagene
HQ
Suzhou, CN
Employees
138↓ 21% decrease
Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.
View companyUT Health San Antonio MD Anderson Cancer Center
HQ
San Antonio, US
UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care.
View companyMirati Therapeutics
HQ
San Diego, US
Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
View company